Picture of Read Gene SA logo

RDG Read Gene SA Income Statement

0.000.00%
pl flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Annual income statement for Read Gene SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.

2019
December 31st
R2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSPRESS
Standards:
PAS
PAS
PAS
PAS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue4.16.076.457.2410.1
Cost of Revenue
Gross Profit3.55.525.756.188.9
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses4.195.576.346.9611.5
Operating Profit-0.0890.5030.1130.286-1.47
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-0.0770.3690.0530.061-1.83
Provision for Income Taxes
Net Income After Taxes-0.0770.3490.0380.213-1.85
Net Income Before Extraordinary Items
Net Income-0.0770.3490.0380.213-1.85
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-0.0770.3490.0380.213-1.85
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-0.0060.030.0030.018-0.195
Dividends per Share